临床诊断市场－全球产业规模、份额、趋势、机会和预测，按检测项目、产品、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球临床诊断市场规模为822.2亿美元，预计2030年将以6.45%的复合年增长率成长至1196.5亿美元。全球临床诊断市场涵盖对生物样本进行的各种实验室检测，用于疾病的检测、诊断、监测和指导治疗。其成长的主要驱动因素包括全球慢性病和传染病患者病率的上升、人口老化加剧以及人们对预防性医疗保健和疾病早期检测意识的提高。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球临床诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依检测项目分类（血脂检查、肝功能检查、肾功能检查、全血球计数、电解质检查、传染病检查、其他检测项目）
  • 依产品分类（仪器、试剂、其他产品）
  • 依最终用户划分（医院实验室、诊断实验室、即时检测、其他最终用户）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美临床诊断市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲临床诊断市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区临床诊断市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲临床诊断市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲临床诊断市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球临床诊断市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Abbott Laboratories, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Siemens Healthineers AG
• Hologic Inc.
• Qiagen NV
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• Quest Diagnostics, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Clinical Diagnostics Market , valued at USD 82.22 Billion in 2024, is projected to experience a CAGR of 6.45% to reach USD 119.65 Billion by 2030. The global clinical diagnostics market encompasses a wide array of laboratory tests performed on biological samples to detect, diagnose, monitor, and guide the management of diseases. Its growth is primarily driven by the increasing worldwide prevalence of chronic and infectious diseases, an expanding aging population, and heightened awareness concerning preventative healthcare and early disease detection.

Key Market Drivers

The increasing prevalence of chronic and infectious diseases constitutes a primary driver for the global clinical diagnostics market. The growing burden of conditions like diabetes, cardiovascular diseases, and various respiratory and other infections necessitates consistent, accurate diagnostic testing for effective disease management, early detection, and public health surveillance. These health challenges generate continuous demand for both routine and specialized diagnostic panels, enabling providers to identify diseases at treatable stages and monitor therapy. For instance, according to the CDC, in November 2024, "2023-2024 Influenza Season Summary: Influenza Severity Assessment, Burden and Burden Prevented", influenza was associated with 40 million illnesses in the United States during the 2023-2024 season, highlighting a significant need for diagnostic tools. This persistent demand underpins the market's growth trajectory.

Key Market Challenges

The complex and evolving global regulatory landscape represents a significant impediment to the growth of the Global Clinical Diagnostics Market. Stringent and often divergent requirements for product approval and market access across various jurisdictions directly contribute to extended development timelines and elevated operational expenditures for manufacturers and innovators. This regulatory burden diverts substantial resources that could otherwise be allocated to research and development or market expansion activities.

For instance, according to MedTech Europe's 2024 Regulatory Survey, certification and maintenance costs for in vitro diagnostic (IVD) devices under new European regulations escalated by 100% or more compared to previous directives. This significant increase directly impacts profitability and the ability of companies to invest in new diagnostic technologies.

Key Market Trends

The decentralization of testing through point-of-care diagnostics significantly influences the market by enabling rapid results and improving patient access outside traditional laboratory settings. This shift supports immediate clinical decision-making across various healthcare environments. A July 2024 Eurostat report indicated that 35.0% of EU residents reported having a chronic health problem in 2023, underscoring the ongoing need for accessible diagnostic tools. This expansion is exemplified by Siemens Healthineers partnering with Carna Health in August 2025 to introduce point-of-care chronic kidney disease testing in emerging markets, integrating an AI-derived platform with existing diagnostics infrastructure for improved early detection. This trend drives demand for portable, user-friendly diagnostic devices.

Key Market Players

• Abbott Laboratories, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Siemens Healthineers AG
• Hologic Inc.
• Qiagen NV
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• Quest Diagnostics, Inc.

Report Scope:

In this report, the Global Clinical Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Diagnostics Market , By Test:

• Lipid Panel
• Liver Panel
• Renal Panel
• Complete Blood Count
• Electrolyte Testing
• Infectious Disease Testing
• Other Tests

Clinical Diagnostics Market , By Product:

• Instruments
• Reagents
• Other Products

Clinical Diagnostics Market , By End User:

• Hospital Laboratory
• Diagnostic Laboratory
• Point-of-care Testing
• Other End Users

Clinical Diagnostics Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Clinical Diagnostics Market .

Available Customizations:

Global Clinical Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Other Tests)
  • 5.2.2. By Product (Instruments, Reagents, Other Products)
  • 5.2.3. By End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-care Testing, Other End Users)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Clinical Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test
  • 6.2.2. By Product
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Clinical Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Clinical Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Clinical Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End User

7. Europe Clinical Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test
  • 7.2.2. By Product
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Clinical Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End User
  • 7.3.2. France Clinical Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Clinical Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Clinical Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Clinical Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End User

8. Asia Pacific Clinical Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test
  • 8.2.2. By Product
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Clinical Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End User
  • 8.3.2. India Clinical Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Clinical Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Clinical Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Clinical Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End User

9. Middle East & Africa Clinical Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test
  • 9.2.2. By Product
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Clinical Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Clinical Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Clinical Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End User

10. South America Clinical Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test
  • 10.2.2. By Product
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Clinical Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Clinical Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Clinical Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Clinical Diagnostics Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Bio-Rad Laboratories, Inc.
• 15.4. Danaher Corporation
• 15.5. Siemens Healthineers AG
• 15.6. Hologic Inc.
• 15.7. Qiagen NV
• 15.8. F. Hoffmann-La Roche Ltd.
• 15.9. Thermo Fisher Scientific, Inc.
• 15.10. Quest Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer